SE436752B - Forfarande for framstellning av nya 16-s-acyl-derivat av fusidinsyra - Google Patents

Forfarande for framstellning av nya 16-s-acyl-derivat av fusidinsyra

Info

Publication number
SE436752B
SE436752B SE7707749A SE7707749A SE436752B SE 436752 B SE436752 B SE 436752B SE 7707749 A SE7707749 A SE 7707749A SE 7707749 A SE7707749 A SE 7707749A SE 436752 B SE436752 B SE 436752B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
new
fusidic acid
acyl derivatives
Prior art date
Application number
SE7707749A
Other languages
English (en)
Other versions
SE7707749L (sv
Inventor
Daehne W Von
P R Rasmussen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of SE7707749L publication Critical patent/SE7707749L/sv
Publication of SE436752B publication Critical patent/SE436752B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027Azides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE7707749A 1976-07-05 1977-07-04 Forfarande for framstellning av nya 16-s-acyl-derivat av fusidinsyra SE436752B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB27921/76A GB1581335A (en) 1976-07-05 1976-07-05 16-s-acyl derivatives of fusidic acid

Publications (2)

Publication Number Publication Date
SE7707749L SE7707749L (sv) 1978-01-06
SE436752B true SE436752B (sv) 1985-01-21

Family

ID=10267438

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7707749A SE436752B (sv) 1976-07-05 1977-07-04 Forfarande for framstellning av nya 16-s-acyl-derivat av fusidinsyra

Country Status (22)

Country Link
US (1) US4119717A (sv)
JP (1) JPS535152A (sv)
AT (1) AT354625B (sv)
AU (1) AU516152B2 (sv)
BE (1) BE856464A (sv)
CA (1) CA1100941A (sv)
DE (1) DE2730196A1 (sv)
DK (1) DK148390B (sv)
FI (1) FI58136C (sv)
FR (1) FR2357574A1 (sv)
GB (1) GB1581335A (sv)
GR (1) GR63210B (sv)
IE (1) IE45217B1 (sv)
IT (1) IT1083082B (sv)
LU (1) LU77683A1 (sv)
NL (1) NL7707221A (sv)
NZ (1) NZ184408A (sv)
PH (1) PH14058A (sv)
PT (1) PT66759B (sv)
SE (1) SE436752B (sv)
YU (1) YU165477A (sv)
ZA (1) ZA773739B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4162259A (en) * 1975-12-03 1979-07-24 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske fabrik Produktionsaktienselskab) Fusidic acid derivatives
US4959358A (en) * 1983-06-06 1990-09-25 Beth Israel Hospital Assn. Drug administration
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
GB9518883D0 (en) * 1995-09-15 1995-11-15 Leo Pharm Prod Ltd Chemical compounds
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
EP2125859B1 (en) * 2006-09-19 2013-05-15 Abbott Products GmbH Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1490852A (en) * 1974-09-12 1977-11-02 Leo Pharm Prod Ltd Fusidic acid derivatives
GR60362B (en) * 1975-06-25 1978-05-19 Leo Pharm Prod Ltd Preparation process of new 16-ethers of fusidic acid derivatives
US4060606A (en) * 1975-06-25 1977-11-29 Leo Pharmaceutical Products Ltd. A/S 16-Ethers of fusidic acid derivatives

Also Published As

Publication number Publication date
PT66759A (en) 1977-08-01
FI58136B (fi) 1980-08-29
GR63210B (en) 1979-10-08
IE45217B1 (en) 1982-07-14
IT1083082B (it) 1985-05-21
ZA773739B (en) 1978-05-30
AU516152B2 (en) 1981-05-21
FR2357574A1 (fr) 1978-02-03
DK148390B (da) 1985-06-24
ATA455777A (de) 1979-06-15
DE2730196A1 (de) 1978-01-19
BE856464A (fr) 1978-01-04
DE2730196C2 (sv) 1987-03-05
AT354625B (de) 1979-01-25
LU77683A1 (sv) 1978-01-31
DK294177A (da) 1978-01-06
IE45217L (en) 1978-01-05
PT66759B (en) 1978-12-14
NL7707221A (nl) 1978-01-09
GB1581335A (en) 1980-12-10
SE7707749L (sv) 1978-01-06
YU165477A (en) 1982-06-30
CA1100941A (en) 1981-05-12
NZ184408A (en) 1980-04-28
US4119717A (en) 1978-10-10
PH14058A (en) 1980-12-29
JPS6238360B2 (sv) 1987-08-17
JPS535152A (en) 1978-01-18
AU2643877A (en) 1979-01-04
FI58136C (fi) 1980-12-10
FR2357574B1 (sv) 1979-07-20
FI772066A (sv) 1978-01-06

Similar Documents

Publication Publication Date Title
DK129477A (da) Fremgangsmade til fremstilling af alkyloximderivater af 7-aminothiazolylacetamidocephalosporansyre
TR19755A (tr) Tereftalik asidin hazirlanmasina mahsus usul
DK23677A (da) Fremgangsmade til fremstilling af oximderivater af 7-aminothiazolyl-acetamidocephalosporansyre
SE7703715L (sv) Framstellning av nya aminokromanoler
NO772652L (no) Fremgangsm}te til fremstilling av fosfonsyrederivater
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
SE7613565L (sv) Forfarande for framstellning av fusidinsyraderivat
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE436752B (sv) Forfarande for framstellning av nya 16-s-acyl-derivat av fusidinsyra
DK12477A (da) Fremgangsmade til fremstilling af 7-aminothiazolylacetamidocephalosporansyrederivater
SE441359B (sv) Forfarande for framstellning av nya klavulansyratioetrar
SE425493B (sv) Forfarande for framstellning av nya estrar av testosteron
DK369677A (da) Fremgangsmaade til fremstilling af oximderivater af 3-carbamoyloxymethyl-7-aminothiazolylacetamidocephalosponsyre
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
NO152451C (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
SE7705183L (sv) Framstellning av nya bensodiazepinderivat
SE421787B (sv) Forfarande for framstellning av kvadratsyra
NO773622L (no) Fremgangsmaate til fremstilling av tereftalsyre
DK86277A (da) Fremgangsmade til fremstilling af clavulamsyrederivater
SE7607322L (sv) Forfarande for framstellning av 16-etrar av fusidinsyraderivat
SE435715B (sv) Forfarande for framstellning av nya penicilliner
SE431655B (sv) Analogiforfaranden for framstellning av nya 9-klorprednisolon-derivat
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat